Catheter-related bloodstream infections with coagulase-negative staphylococci: are antibiotics necessary if the catheter is removed?

[1]  B. Souweine,et al.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill , 2018, Intensive Care Medicine.

[2]  L. Leibovici,et al.  Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  Matthew H Samore,et al.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Sun-Dong Park,et al.  Coagulase-negative staphylococcal bacteremia: risk factors for mortality and impact of initial appropriate antimicrobial therapy on outcome , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[5]  T. Whitehouse,et al.  Vancomycin-Associated Nephrotoxicity in the Critically Ill: A Retrospective Multivariate Regression Analysis* , 2014, Critical care medicine.

[6]  D. Lebeaux,et al.  Management of infections related to totally implantable venous-access ports: challenges and perspectives. , 2014, The Lancet. Infectious diseases.

[7]  F. Bella,et al.  Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  E. Cordero,et al.  Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. , 2013, The Journal of infection.

[9]  J. Ruiz,et al.  [Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment]. , 2012, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

[10]  J. Timsit,et al.  New challenges in the diagnosis, management, and prevention of central venous catheter-related infections. , 2011, Seminars in respiratory and critical care medicine.

[11]  I. Raad,et al.  Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Ioanna Dimopoulou,et al.  Impact of catheter-related bloodstream infections on the mortality of critically ill patients: A meta-analysis* , 2009, Critical care medicine.

[13]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Sakoulas,et al.  Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses , 2008, Antimicrobial Agents and Chemotherapy.

[15]  A Lepape,et al.  European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. , 2007, The Journal of hospital infection.

[16]  J. Rodríguez-Baño,et al.  [Guidelines for the diagnosis and treatment of patients with bacteriemia. Guidelines of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. , 2007, Enfermedades infecciosas y microbiologia clinica.

[17]  J. Cisneros,et al.  Guía para el diagnóstico y tratamiento del paciente con bacteriemia. Guías de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) , 2007 .

[18]  Johan Decruyenaere,et al.  Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  R. Gaynes,et al.  Monitoring Antimicrobial Use and Resistance: Comparison with a National Benchmark on Reducing Vancomycin Use and Vancomycin-Resistant Enterococci , 2002, Emerging infectious diseases.

[20]  R. Wenzel,et al.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay , 1990 .

[21]  M Rapin,et al.  Diagnosis of Central Venous Catheter-Related Sepsis: Critical Level of Quantitative Tip Cultures , 1987 .

[22]  E. García-Vázquez,et al.  Bacteriemias por Staphylococcus coagulasa negativa: análisis de factores pronóstico e influencia del tratamiento antibiótico , 2012 .

[23]  M. A. Martin,et al.  Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. , 1989, Annals of internal medicine.

[24]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.